Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials
Research output: Contribution to journal › Comment/debate › Research › peer-review
Original language | English |
---|---|
Journal | Journal of Internal Medicine |
Volume | 295 |
Issue number | 5 |
Pages (from-to) | 707-710 |
ISSN | 0954-6820 |
DOIs |
|
Publication status | Published - 2024 |
- coronary disease, lipids, myocardial infarction, stroke, triglycerides-rich lipoproteins, very low-density lipoproteins
Research areas
ID: 383885109